IL150742A0
(en )
2003-02-12
Pyridopyrimidinone derivatives for the treatment of neurodegenerative disease
IL145470A0
(en )
2002-06-30
Compositions for the treatment of immune diseases
IL196301A0
(en )
2009-09-22
Medicament for the treatment of hapatitis c
PL362711A1
(en )
2004-11-02
Morpholin-acetamide derivatives for the treatment of inflammatory diseases
GB0010669D0
(en )
2000-06-28
Compositions for treatment of disorders of the oesophagus
IL151890A0
(en )
2003-04-10
Hydroxyphenyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
EP1463527A4
(en )
2005-05-11
The use of gammaglobulin for the treatment of immune-mediated diseases
HUP0104963A3
(en )
2002-11-28
Compositions for the treatment of skin diseases
IL153831A0
(en )
2003-07-31
Methods for therapy of neurodegenerative disease of the brain
IL151765A0
(en )
2003-04-10
Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
AU2266801A
(en )
2001-07-03
Combination therapy for treating neurodegenerative disease
HK1038510B
(en )
2005-05-20
Use of neurotrophic factor stimulators for the treatment of ophthalmic neurodegenerative diseases
AU4215499A
(en )
2002-07-08
Treatment of neurodegenerative diseases
PL373490A1
(en )
2005-09-05
Use of beta-adrenoceptor agonists for the treatment of neurodegenerative diseases
GB9900222D0
(en )
1999-02-24
Therapeutic compounds
ZA200110539B
(en )
2003-03-24
Oxazinocarbazoles for the treatment of CNS diseases.
AU3004000A
(en )
2000-09-14
Methods for the treatment of apolipoprotein e related diseases
IL153439A0
(en )
2003-07-06
Medicines for the prevention and treatment of neurodegenerative diseases
SI1185293T1
(en )
2006-02-28
Il6ril6 chimera for the treatment of neurodegenerative diseases
ZA991783B
(en )
1999-09-06
Therapeutic treatment for autoimmune diseases.
GB9904252D0
(en )
1999-04-21
Composition for the treatment of pain
AU5854799A
(en )
2000-03-14
Novel treatment of neurodegenerative diseases
IL147188A0
(en )
2002-08-14
Il6ril6 chimera for the treatment of demyelinating diseases
AU2002344959A1
(en )
2003-11-17
Use of fasl for the treatment of neurodegenerative diseases
SI1200447T1
(en )
2004-04-30
Oxazinocarbazoles for the treatment of cns diseases